Key result
Variant rs75542274 linked to ~414% greater risk of radiation-induced fibrosis in breast cancer.
Why the study?
Radiation-induced fibrosis remains a significant late morbidity after breast cancer radiotherapy, but its underlying genetic architecture is incompletely understood.
Observational (n=869)
Yes
Effect estimate: OR 5.14 (95% CI 2.85-9.30)
p-value: p=5.9 x 10^-8
This exploratory GWAS identified a suggestive, near-significant susceptibility locus (rs75542274) on chromosome 10 for radiation-induced fibrosis in breast cancer patients, which requires independent validation.
Genetic risk prediction of post-RT fibrosis is not clinically actionable; leaves open further genetic discovery and validation.
Abstract Background and purpose Radiation-induced fibrosis affects women having undergone post-lumpectomy radiotherapy to a varying degree and remains a significant late morbidity for breast cancer patients. While Single Nucleotide Polymorphisms (SNPs) have been linked to fibrosis after radiotherapy (RT), the genetic architecture remains incompletely understood. We aimed to identify new genetic variants in a cohort of early breast cancer patients representing two cohorts treated within the Danish Breast Cancer Group (DBCG) protocols. Material and methods A genome-wide association study (GWAS) was conducted on 869 patients treated with lumpectomy and adjuvant radiotherapy within the DBCG trials hypo- versus normofractionated radiotherapy trial, DBCG-HYPO, and the DBCG partial versus whole breast irradiation trial, DBCG-PBI. After genotyping and imputation, we tested associations between common variants and grade 2–3 fibrosis (LENT-SOMA) using a per-risk allele log-additive model. The threshold for genome-wide significance was set atP < 5 × 10⁻⁸. Results After adjusting for principal component outliers, we identified a suggestive association on chromosome 10 (P = 5.90 × 10⁻⁸). The lead variant was rs75542274. While this locus approached the pre-defined genome-wide significance threshold, no other variants reached significance. Conclusion This exploratory GWAS identified a potential susceptibility locus for radiation-induced fibrosis on chromosome 10. Given the near-significant nature of this finding, independent validation or meta-analysis is required to confirm the role of rs75542274 in the development of RT-induced fibrosis. Further analysis is warranted.
No takes yet. Share an insight, caveat, or question.
Schack et al. (2026) conducted an observational in Early breast cancer (radiation-induced fibrosis) (n=869). Minor allele C in rs75542274 (Chromosome 10) vs. Major allele was evaluated on Grade ≥2 breast induration/fibrosis (LENT-SOMA) at 3 years after radiotherapy (OR 5.14, 95% CI 2.85-9.30, p=5.9 x 10^-8). The minor allele C in rs75542274 on chromosome 10 showed a suggestive association with an increased risk of grade 2-3 radiation-induced fibrosis (OR 5.14) in breast cancer patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: